Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings

Archives of General Psychiatry

Volumn 57, Issue 9, 2000, Pages 875-882

  Musselman, Dominique L ^b   Marzec, Ulla M ^b   Manatunga, Amita ^c   Penna, Suzanne ^b   Reemsnyder, Andrea ^b   Knight, Bettina T ^b   Baron, Aimee ^b   Hanson, Stephen R ^b   Nemeroff, Charles B ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PAROXETINE;

ADULT; ANTIGEN BINDING; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

EID: 0033857466     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.9.875     Document Type: Article

References (50)

1. Depression in the workplace: An economic perspective
2. Lost human capital from early-onset chronic depression
3. Patterns of functional and symptomatic response over two years of sertraline therapy for chronic depression
4. The effects of chronic medical conditions in work impairment
5. Depression in the workplace: Effects on short-term work disability
6. Affective disorders and mortality: A general population study
7. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults
8. Depression and cardiovascular diseases
9. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer
10. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
11. Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up
12. Depression is a risk factor for coronary artery disease in men: The Precursors Study
13. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults
14. Mortality, symptoms, and functional impairment in late-life depression
15. Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991
16. Major depressive disorder predicts cardiac events in patients with coronary artery disease
17. The nature and course of depression following myocardial infarction
18. Depression following myocardial infarction: Impact on 6-month survival
19. Depression in patients with coronary artery disease
20. Major depressive disorder in coronary artery disease
21. Depression and 18-month prognosis after myocardial infarction
22. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)
23. Exaggerated platelet reactivity in major depression
24. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease
25. Effects of sertraline treatment of depression on platelet activation in an open-label study: Implications for coronary disease
26. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease
27. Antiplatelet and anatithrombin therapies in the acute coronary syndromes
28. Decreased uptake of 3H-serotonin and endogeneous content of serotonin in blood platelets in hypertensive patients
29. 5HT-kinetics and sensitivity of human blood platelets: Variations with age, gender and platelet number
30. Low-density lipoprotein amplifies the platelet response to serotonin in human plasma
31. 5-Hydroxytryptamine kinetics and activation of blood platelets in patients with essential hypertension
32. Platelet serotonin-LDL interaction in essential hypertension
33. Cigarette smoking and platelet-vessel wall interactions
34. The family history method using diagnostic criteria: Reliability and validity
35. Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and healthy controls
36. Comparison of β-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation
37. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment
38. The assessment of anxiety states by rating
39. Hamilton Anxiety Rating Scale Interview Guide: Joint interview and test-retest methods for interrater reliability
40. A rating scale for depression
41. A structured interview version of the Hamilton Depression Rating Scale: Evidence of reliability and versatility of administration
42. The Carroll Rating Scale for Depression, II: Factor analyses of the feature profiles
43. The Carroll Rating Scale for Depression, I: Development, reliability and validation
44. 1993 Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting
45. Guidelines for healthy weight
46. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults